Search
Ethambutol
go.drugbank.com/drugs/DB00330ApprovedInvestigationalEthambutol is a bacteriostatic agent indicated alongside medications such as [isoniazid], [rifampin], and [pyrazinamide] in the treatment of pulmonary tuberculosis. … [L31743] Ethambutol was first described in the literature in 1961.[A229048] It was developed out of a need for therapies active against isoniazid resistant strains of _Mycobacterium tuberculosis_.
Categories: ethambutol and isoniazid, rifampicin, ethambutol and isoniazidSynonyms: (+)-N,N'-bis(1-(hydroxymethyl)propyl)ethylenediaminePivampicillin
go.drugbank.com/drugs/DB01604ApprovedWithdrawnPivalate ester analog of ampicillin.
Products: Pondocillin Tab 500mgButorphanol
go.drugbank.com/drugs/DB00611ApprovedIllicitVet approvedIt is used in the management of severe pain.
Synonyms: (−)-N-cyclobutylmethyl-3,14-dihydroxymorphinanProducts: Stadol NS - 10mg/ml Aem-liqErythropoietin Resistant Anemia (EPO Resistant Anemia)
go.drugbank.com/conditions/DBCOND0161719Drugs: VadadustatSynonyms: Anemia in Chronic Kidney Diseases, Anaemia in Chronic Kidney DiseaseTestosterone enanthate
go.drugbank.com/drugs/DB13944ApprovedInvestigationalTestosterone enanthate is an esterified variant of testosterone that comes as an injectable compound with a slow-release rate. … The majority of the prescriptions written were for injectable (66%) and topical (32%) testosterone products. As recent as 1 October 2018, the US FDA approved Antares Pharma Inc.'
Categories: Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone AntagonistsProducts: Testosterone Enanthate Inj 200mg/ml, PMS-testosterone Enanthate Inj 200mg/ml USP(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE
go.drugbank.com/drugs/DB07964ExperimentalSynonyms: (3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDEUncomplicated veins 1 to 3 mm in diameter reticular veins
go.drugbank.com/conditions/DBCOND0025659Drugs: PolidocanolSynonyms: Uncomplicated veins 1 to 3 mm in diameter reticular veinsCarfilzomib
go.drugbank.com/drugs/DB08889ApprovedInvestigationalCarfilzomib is an injectable antineoplastic agent (IV only). Chemically, it is a modified tetrapeptidyl epoxide and an analog of epoxomicin. It is also a selective proteasome inhibitor. … FDA approved carfilzomib in July 2012 for the treatment of adults with relapsed or refractory multiple myeloma as monotherapy or combination therapy.[L39392]
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsProducts: KYPROLIS POWDER FOR SOLUTION FOR INFUSION 60MG/VIAL, Kyprolis (carfilzomib) powder for solution for infusion 60mg/vialBurosumab
go.drugbank.com/drugs/DB14012ApprovedInvestigationalBurosumab (KRN23) is an entirely human monoclonal IgG1 antibody that binds excess fibroblast growth factor 23 (FGF23) and has been successfully tested in clinical trials in children with X-linked hypophosphatemic … It causes impaired bone growth and development in children and adolescents and issues with bone mineralization throughout a patient’s life [L2346].
Categories: Amino Acids, Peptides, and Proteins, Drugs Affecting Bone Structure and MineralizationProducts: CRYSVITA ® SOLUCION PARA INYECCIÓN 10MG/ML